Cited by 7Gestational Diabetes Research and ManagementPregnancy and preeclampsia studiesBirth, Development, and Health

Biomarkers of Gestational Diabetes Mellitus: Mechanisms, Advances, and Clinical Utility

Pramodkumar, Thyparambil Aravindakshan, Hannah, Wesley, Anjana, Ranjit Mohan, Ram, Uma, Tiwaskar, Mangesh, Gokulakrishnan, Kuppan, Popova, Polina V, Mohan, Viswanathan·2025·Journal of The Association of Physicians of India

Abstract

Gestational diabetes mellitus (GDM) continues to pose a significant challenge to maternal and fetal health, driving the need for advanced diagnostic and therapeutic strategies. Biomarker discovery has proven essential for early detection, mechanistic insights, and targeted interventions. This review provides an in-depth examination of biomarkers related to GDM, focusing on glucose metabolism, insulin resistance, inflammatory signaling, adipokines, oxidative stress markers, and genetic/epigenetic determinants. We also evaluate novel biomarkers emerging from omics technologies and their translational potential in clinical practice. Additionally, we explore the role of microRNAs and extracellular vesicles as emerging biomarkers that could offer new perspectives on GDM pathophysiology. Integration of these biomarkers into predictive models holds the potential to improve risk assessment and patient health outcomes.

Integrity signals

Registry

Crossref · 10.59556/japi.73.0849

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Placental and circulating miRNAs can modulate gene expression through epigenetic mechanisms and may alter key developmental pathways including PPAR, mTOR, WNT, and insulin/IGF signaling.

    “Importantly, placental and circulating miRNAs can modulate gene expression through epigenetic mechanisms and may alter key developmental pathways, including PPAR, mTOR, WNT, and insulin/IGF signaling, thereby influencing fetal growth patterns and long-term disease risk [41,43,44,45].”
  • Circulating miRNAs dysregulated in GDM are implicated in inflammation, endothelial dysfunction, lipid and glucose metabolism, and insulin signaling.

    “Several miRNAs dysregulated in GDM have been implicated in inflammation, endothelial dysfunction, lipid and glucose metabolism, and insulin signaling.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pramodkumar, T. A., Hannah, W., Anjana, R. M., Ram, U., Tiwaskar, M., Gokulakrishnan, K., Popova, P. V., & Mohan, V.
Affiliations
  • Madras Diabetes Research Foundation (IN)
  • Seethapathy Clinic and Hospital (IN)
  • National Institute of Mental Health and Neurosciences (IN)
  • Federal Almazov North-West Medical Research Centre (RU)
Venue
Journal of The Association of Physicians of India
Published
2025-02
Volume
73
Issue
2
Pages
56-67
ISSN
0004-5772 (ISSN-L)
OpenAlex
W4407348603
Cited by
7
References
5
Citations by year
2026: 4 · 2025: 3
FWCI
1.54
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the Association of Physicians of India (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
gestational diabetes mellitus, biomarkers, glucose metabolism, insulin resistance, inflammation, adipokines, oxidative stress, epigenetics, omics, microRNA, extracellular vesicles, risk prediction, early diagnosis
MeSH terms
Female, Humans, Insulin Resistance, Pregnancy, Biomarkers, Diabetes, Gestational, Oxidative Stress, MicroRNAs, Adipokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review